316 related articles for article (PubMed ID: 31489524)
21. Tet-Mediated DNA Demethylation Is Required for SWI/SNF-Dependent Chromatin Remodeling and Histone-Modifying Activities That Trigger Expression of the Sp7 Osteoblast Master Gene during Mesenchymal Lineage Commitment.
Sepulveda H; Villagra A; Montecino M
Mol Cell Biol; 2017 Oct; 37(20):. PubMed ID: 28784721
[TBL] [Abstract][Full Text] [Related]
22. Histone modification: cause or cog?
Henikoff S; Shilatifard A
Trends Genet; 2011 Oct; 27(10):389-96. PubMed ID: 21764166
[TBL] [Abstract][Full Text] [Related]
23. Epigenetic impairments in development of parthenogenetic preimplantation mouse embryos.
Ho NTK; Nguyen TVT; Nguyen TV; Bui HT
J Reprod Dev; 2019 Feb; 65(1):83-90. PubMed ID: 30606958
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic Regulation of Early- and Late-Response Genes in Acute Pancreatitis.
Sandoval J; Pereda J; Pérez S; Finamor I; Vallet-Sánchez A; Rodríguez JL; Franco L; Sastre J; López-Rodas G
J Immunol; 2016 Nov; 197(10):4137-4150. PubMed ID: 27798150
[TBL] [Abstract][Full Text] [Related]
25. Deregulation of histone-modifying enzymes and chromatin structure modifiers contributes to glioma development.
Maleszewska M; Kaminska B
Future Oncol; 2015 Sep; 11(18):2587-601. PubMed ID: 26289459
[TBL] [Abstract][Full Text] [Related]
26. Molecular Pathways: Metabolic Control of Histone Methylation and Gene Expression in Cancer.
Tran TQ; Lowman XH; Kong M
Clin Cancer Res; 2017 Aug; 23(15):4004-4009. PubMed ID: 28404599
[TBL] [Abstract][Full Text] [Related]
27. Early loss of Crebbp confers malignant stem cell properties on lymphoid progenitors.
Horton SJ; Giotopoulos G; Yun H; Vohra S; Sheppard O; Bashford-Rogers R; Rashid M; Clipson A; Chan WI; Sasca D; Yiangou L; Osaki H; Basheer F; Gallipoli P; Burrows N; Erdem A; Sybirna A; Foerster S; Zhao W; Sustic T; Petrunkina Harrison A; Laurenti E; Okosun J; Hodson D; Wright P; Smith KG; Maxwell P; Fitzgibbon J; Du MQ; Adams DJ; Huntly BJP
Nat Cell Biol; 2017 Sep; 19(9):1093-1104. PubMed ID: 28825697
[TBL] [Abstract][Full Text] [Related]
28. Epigenetic mechanisms: critical contributors to long-term memory formation.
Lubin FD; Gupta S; Parrish RR; Grissom NM; Davis RL
Neuroscientist; 2011 Dec; 17(6):616-32. PubMed ID: 22130638
[TBL] [Abstract][Full Text] [Related]
29. Epigenetic control of ovarian function: the emerging role of histone modifications.
LaVoie HA
Mol Cell Endocrinol; 2005 Nov; 243(1-2):12-8. PubMed ID: 16219412
[TBL] [Abstract][Full Text] [Related]
30. Epigenetic regulation and chromatin remodeling in learning and memory.
Kim S; Kaang BK
Exp Mol Med; 2017 Jan; 49(1):e281. PubMed ID: 28082740
[TBL] [Abstract][Full Text] [Related]
31. Epigenetic regulatory mutations and epigenetic therapy for multiple myeloma.
Dupéré-Richer D; Licht JD
Curr Opin Hematol; 2017 Jul; 24(4):336-344. PubMed ID: 28441149
[TBL] [Abstract][Full Text] [Related]
32. The epigenomics of sarcoma.
Nacev BA; Jones KB; Intlekofer AM; Yu JSE; Allis CD; Tap WD; Ladanyi M; Nielsen TO
Nat Rev Cancer; 2020 Oct; 20(10):608-623. PubMed ID: 32782366
[TBL] [Abstract][Full Text] [Related]
33. Targeting Chromatin Remodeling for Cancer Therapy.
Kaur J; Daoud A; Eblen ST
Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
[TBL] [Abstract][Full Text] [Related]
34. Epigenetic regulation by BAF (mSWI/SNF) chromatin remodeling complexes is indispensable for embryonic development.
Nguyen H; Sokpor G; Pham L; Rosenbusch J; Stoykova A; Staiger JF; Tuoc T
Cell Cycle; 2016 May; 15(10):1317-24. PubMed ID: 26986003
[TBL] [Abstract][Full Text] [Related]
35. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
36. Driver mutations of cancer epigenomes.
Roy DM; Walsh LA; Chan TA
Protein Cell; 2014 Apr; 5(4):265-96. PubMed ID: 24622842
[TBL] [Abstract][Full Text] [Related]
37. Chromatin modifying gene mutations in follicular lymphoma.
Green MR
Blood; 2018 Feb; 131(6):595-604. PubMed ID: 29158360
[TBL] [Abstract][Full Text] [Related]
38. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
Herranz M; Esteller M
Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
[TBL] [Abstract][Full Text] [Related]
39. Chromatin regulators with tumor suppressor properties and their alterations in human cancers.
Shu XS; Li L; Tao Q
Epigenomics; 2012 Oct; 4(5):537-49. PubMed ID: 23130835
[TBL] [Abstract][Full Text] [Related]
40. Differential Expression of SWI/SNF Chromatin Remodeler Subunits Brahma and Brahma-Related Gene During Drug-Induced Liver Injury and Regeneration in Mouse Model.
Sinha S; Verma S; Chaturvedi MM
DNA Cell Biol; 2016 Aug; 35(8):373-84. PubMed ID: 27097303
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
